ArticleThe Journal of physiology2025
Photoreceptor degeneration has heterogeneous effects on functional retinal ganglion cell types.
Article in The Journal of physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A large-scale dataset of functional mouse ganglion cell layer responses.Scientific data · 2026Article
- Transplantation of human stem cell-derived cone photoreceptors partially restores vision in aged rd1 mice with advanced retinal degeneration.Stem cells (Dayton, Ohio) · 2026Article
- Adaptation of visual responses in degeneratingFrontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Retinitis pigmentosa is a hereditary disease-causing progressive degeneration of rod and cone photoreceptors, with no effective therapies. Using rd10 mice, which mirror the human condition, we examined its disease progression. Rods deteriorate by postnatal day (P) 45, followed by cone degeneration, with most photoreceptors lost by P180. Until then, retinal ganglion cells (RGCs) remain light-responsive under photopic conditions, despite extensive outer retinal remodelling. However, it is still unknown if distinct functional RGC types alter their activity or are even lost during disease progression. Here, we asked if and how the response diversity of functional RGC types changes with rd10 disease progression. At P30, we identified all functional wild-type RGC types also in rd10 retinae, suggesting that at this early degenerative stage, the full breadth of retinal output is still present. Remarkably, we found that the fractions of functional types changed throughout progressing degeneration between rd10 and wild-type: responses of RGCs with 'Off'-components ('Off' and 'On-Off' RGCs) were more vulnerable than 'On'-cells, with 'Fast On' types being the most resilient. Notably, direction-selective RGCs appeared to be more vulnerable than orientation-selective RGCs. In summary, we found differences in resilience of response types (from resilient to vulnerable): 'Uncertain' > 'Fast On' > 'Slow On' > 'On-Off' > 'Off'. Taken together, our results suggest that rd10 photoreceptor degeneration has heterogeneous effects on functional RGC types, with distinct sets of types losing their characteristic light responses earlier than others. This differential susceptibility of RGC circuits may be of relevance for future neuroprotective therapeutic strategies. KEY POINTS: Retinitis pigmentosa is a hereditary disease causing progressive degeneration of rod and cone photoreceptors, with no effective therapies; it can be investigated using mutant mouse models, like rd10, that mirror the human condition. Recent studies found that retinal ganglion cells (RGCs) in rd10 remain light-responsive, despite extensive loss of photoreceptors and outer retinal remodelling; however, specific RGC types still may change or even lose their functional response profile during early degeneration. Using two-photon calcium imaging, we assessed if and how the light-evoked activity of RGCs, and, hence, the retinal output to the brain, differs during the disease progression in rd10 compared to wild-type mice. We found differences in the resilience of functional RGC types: generally, 'On'-types were more resilient than 'On-Off' or especially 'Off' types. Our data suggest that interventions may be more effective in the 'On' pathways, which turned out to be more resilient in rd10.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.